Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Possible birthplace of malignant brain tumors identified

Possible birthplace of malignant brain tumors identified

July 20, 2006

Researchers have found that abnormal stimulation of a cellular trigger that normally regulates replenishment of brain cells in adults causes invasive tumor-like growths in mice. Removing the abnormal stimulation causes the growths to regress-a finding the researchers said suggests a possible treatment for the lethal, aggressive brain tumors called malignant gliomas.

Arturo Alvarez-Buylla and Erica L. Jackson, of the University of California, San Francisco, and colleagues reported their findings in a paper in the July 20, 2006, Neuron, published by Cell Press. In their studies, they sought to discover whether neural stem cells in the brain called B cells carry a receptor-known as platelet-derived growth factor receptor á (PDGFRá)-for the signaling molecule PDGF.




Neural stem cells are immature cells that serve as the continual source of new brain cells in adults, and PDGF is known as an important regulator of such cells. Also, PDGF has been implicated as a key signaling molecule underlying the formation of brain tumors. PDGF triggers such cell response by plugging into the target receptor on the stem cell, like a key inserting into a lock.

There had been indirect evidence that neural stem cells give rise to brain tumors. "However, it has not been shown in vivo that tumor stem cells are derived from normal stem cells or that a specific population of cells with demonstrated stem cell properties is capable of initiating tumor formation," wrote the researchers.

Using tracers, the researchers discovered that PDGFRá is, indeed, found on the stem cells in both mouse and human brain tissue. They also found that the receptor is triggered by PDGF in the stem cells to regulate their production of mature brain cells. The researchers located the PDGFRá-containing cells in the subventricular zone (SVZ) of the brain, which is the center for production of new brain cells in adults.

The researchers also found that infusing PDGF into mouse brain caused abnormal growth-called hyperplasia-of tumor-like nodules that invaded surrounding brain tissue. Their analysis indicated that the PDGF infusion caused the stem cells to halt their normal production of mature brain cells and launch into the abnormal proliferation pathway. Importantly, the researchers found that stopping the PDGF infusion caused a complete regression of the nodules.

The researchers wrote that "these findings are significant due to our limited knowledge of surface markers for neural stem cells. Our data also provide evidence of a link between these PDGFRá B cells and the early changes associated with tumor initiation, suggesting they may be targets of neoplastic transformation. The regression of atypical hyperplasia after PDGF removal described here suggests that inhibition of PDGF signaling could provide a useful therapy for those gliomas in which the pathway is upregulated, especially given the recovery of the normal architecture after regression of the hyperplasia."

In a preview of the paper in the same issue of Neuron, Santosh Kesari and Charles D. Stiles wrote that the new findings "lend weight" to the argument that the stem cells identified by Alvarez-Buylla and his colleagues are the cells or origin for malignant gliomas. They wrote that such work offers "therapeutic opportunities," emphasizing that "the people that matter the most do not have the luxury of time to watch this work unfold. The median interval from diagnosis to death for patients with malignant glioma is currently only 14 months."

Cell Press



Related Malignant Brain Tumors Current Events and Malignant Brain Tumors News Articles Malignant Brain Tumors Current Events and Malignant Brain Tumors News RSS Malignant Brain Tumors Current Events and Malignant Brain Tumors News RSS
Researchers Identify Role of Gene in Tumor Development, Growth and Progression
Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis.

Researchers report benefits of new standard treatment study for rare pediatric brain cancer
A team of researchers led by The University of Texas M. D. Anderson Cancer Center unveiled results today from the largest-ever collaborative study addressing the treatment of a rare pediatric brain tumor.

New Approach for the Treatment of Malignant Brain Tumors
Initial chemotherapy alone after surgery is just as successful as initial radiation therapy for patients from whom a very malignant brain tumor (anaplastic glioma) was removed. With this treatment, the patients survive on average > 30 months without a recurrence.

Why don't brain tumors respond to medication?
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance.

Study provides documentation that tumor 'stem-like cells' exist in benign tumors
Cancer stem-like cells have been implicated in the genesis of a variety of malignant cancers. Research scientists at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute have isolated stem-like cells in benign (pituitary) tumors and used these "mother" cells to generate new tumors in laboratory mice.

Gliomas exploit immune cells of the brain for rapid expansion
Gliomas are among the most common and most malignant brain tumors. These tumors infiltrate normal brain tissue and grow very rapidly. As a result, surgery can never completely remove the tumor.

Stealthy gene network makes brain tumors flourish
The brain tumor afflicting Sen. Edward Kennedy - a glioblastoma - is the most aggressive and wily form of brain cancer.

Anti-angiogenesis treatment improves hearing in some NF2 patients
Treatment with the angiogenesis inhibitor bevacizumab improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 (NF2).

Variations in 5 genes raise risk for most common brain tumors
Common genetic variations spread across five genes raise a person's risk of developing the most frequent type of brain tumor, an international research team reports online in Nature Genetics.

Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme.
More Malignant Brain Tumors Current Events and Malignant Brain Tumors News Articles
  Therapy of Malignant Brain Tumors
by Kurt Jellinger (Editor)



Stella's Story: Fighting for Life Against a Malignant Brain Tumor

Stella's Story: Fighting for Life Against a Malignant Brain Tumor
by Kay Loveland (Author)

I wish there had been a book like this when I was fighting alongside my partner, Stella, as her 24/7 caregiver in a 19-month battle against the deadliest brain tumor, glioblastoma multiforme (GBM). Too often I felt sideswiped by unexpected obstacles. The Internet was a great resource, but having a book at hand illuminating the day-to-day struggle--treatments, questions, decisions, emotions, surprises--would have helped immensely.

After Stella died in November 2000, I wanted to write such a guidebook for caregivers and patients who, sadly, are following in our footsteps. As I reviewed hundreds of e-mails to and from friends, Brain Tumor List members, doctors, and others, I realized the book was already written. It provides an almost-daily, immediate chronicle of our experiences,...

  Third malignant brain tumor transmitted by liver transplant raises concern in U.K.: An article from: Transplant News
by Transplant Communications, Inc. (Publisher)

This digital document is an article from Transplant News, published by Transplant Communications, Inc. on August 12, 1998. The length of the article is 506 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Third malignant brain tumor transmitted by liver transplant raises concern in U.K.
Publication: Transplant News (Newsletter)
Date: August 12, 1998
Publisher: Transplant Communications, Inc.
Volume: 8 Issue: 15 Page: N/A

Distributed by Thomson...

  Blood-brain barrier disruption for the treatment of malignant brain tumors: the national program.: An article from: Journal of Neuroscience Nursing
by Nancy D. Doolittle (Author), Annie Petrillo (Author), Susan Bell (Author), Pamela Cummings (Author), Sharon Eriksen (Author)

This digital document is an article from Journal of Neuroscience Nursing, published by American Association of Neuroscience Nurses on April 1, 1998. The length of the article is 6451 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the supplier: Blood-brain barrier disruption (BBBD) can substantially improve the effectiveness of chemotherapy drugs in the treatment of cancerous brain tumors. The Blood-Brain Barrier Program at Oregon Health Sciences University in Portland coordinates the procedures at six medical centers. Concentrated mannitol is administered to the anesthetized patient, causing...

Case-control study of the association between the use of cellular and cordless telephones and malignant brain tumors diagnosed during 2000-2003 [An article from: Environmental Research]

Case-control study of the association between the use of cellular and cordless telephones and malignant brain tumors diagnosed during 2000-2003 [An article from: Environmental Research]
by L. Hardell (Author), M. Carlberg (Author), K.H. Mild (Author)

This digital document is a journal article from Environmental Research, published by Elsevier in . The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
We performed a case-control study on the use of cellular and cordless telephones and the risk for brain tumors diagnosed during 2000-2003. We report the results for malignant brain tumors with data from 317 cases (88%) and 692 controls (84%). The use of analog cellular phones yielded odds ratio (OR) of 2.6 and a 95% confidence interval (CI) of 1.5-4.3, increasing to OR=3.5 and 95% CI=2.0-6.4 with a >10-year latency period. Regarding digital cellular telephones, the corresponding results were OR=1.9, 95% CI=1.3-2.7...

  Stereotactic radiosurgery for malignant brain tumors: the patient's perspective.: An article from: Journal of Neuroscience Nursing
by Peggy Ward-Smith (Author)

This digital document is an article from Journal of Neuroscience Nursing, published by American Association of Neuroscience Nurses on April 1, 1997. The length of the article is 4315 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the supplier: The patient's viewpoint on stereotactic radiosurgery for primary malignant brain tumors was obtained from interviews with eight such patients using Colaizzi's phenomenological technique. Major themes included the willingness to undergo the procedure again and the lack of discomfort compared to other treatments. The patients educated themselves about the Gamma...

  Malignant Brain Tumors
by David G. Thomas (Author), David I. Graham (Editor)

The National Hospital, London, U.K. Reference on the basic science and clinical aspects of adult and pediatric brain tumors. Includes treatment modalities. For neurologists and pathologists. Color plates and halftone illustrations. 28 contributors, 21 U.S.

  Neuro-Oncology: Primary Malignant Brain Tumors (Johns Hopkins Series in Contemporary Medicine and Public Health)
by Professor David G. T. Thomas (Editor)



  Atlas of Pediatric Brain Tumors
by Adekunle M. Adesina (Editor), Tarik Tihan (Editor), Christine E. Fuller (Editor), Tina Young Poussaint (Editor)

Recent evidence indicates that the physiology and response to various drugs in the pediatric population differs from that of the adult and must be appreciated to be able to fully address the health needs of the pediatric population. Atlas of Pediatric Brain Tumors covers areas ranging from neuroimaging, the use of crush and touch preps during introperative consultation, classic histological features of brain tumors, tumor variants, and a miscellaneous group of challenging tumors. Chapters consist of essential diagnostic information and features highlighting recognized variants and their differential diagnoses. A section on molecular pathology and electron microscopy is also included for each tumor category; along with a list of classic reviews and innovative articles on each of the...

  Management of Malignant Brain Tumors: A Team Approach
by Marcel Dekker Inc (Publisher)



© 2009 BrightSurf.com